Global burden of disease from alcohol, illicit drugs and tobacco
- PMID: 17132570
- DOI: 10.1080/09595230600944453
Global burden of disease from alcohol, illicit drugs and tobacco
Abstract
The use of alcohol, tobacco and illicit drugs entails considerable burden of disease: in 2000, about 4% of the global burden as measured in disability adjusted life years was attributable to each alcohol and tobacco, and 0.8% to illicit drugs. The burden of alcohol in the above statistic was calculated as net burden, i.e. incorporating the protective health effects. Tobacco use was found to be the most important of 25 risk factors for developed countries in the comparative risk assessment underlying the data. It had the highest mortality risk of all the substance use categories, especially for the elderly. Alcohol use was also important in developed countries, but constituted the most important of all risk factors in emerging economies. Alcohol use affected younger people than tobacco, both in terms of disability and mortality. The burden of disease attributable to the use of legal substances clearly outweighed the use of illegal drugs. A large part of the substance-attributable burden would be avoidable if known effective interventions were implemented.
Similar articles
-
Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs.Drug Alcohol Rev. 2006 Nov;25(6):515-36. doi: 10.1080/09595230600944461. Drug Alcohol Rev. 2006. PMID: 17132571 Review.
-
Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use.Drug Alcohol Rev. 2006 Nov;25(6):553-65. doi: 10.1080/09595230600944487. Drug Alcohol Rev. 2006. PMID: 17132573 Review.
-
Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002.Addiction. 2006 Aug;101(8):1086-95. doi: 10.1111/j.1360-0443.2006.01491.x. Addiction. 2006. PMID: 16869838
-
Global use of alcohol, drugs and tobacco.Drug Alcohol Rev. 2006 Nov;25(6):489-502. doi: 10.1080/09595230600944446. Drug Alcohol Rev. 2006. PMID: 17132569 Review.
-
A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.Drug Alcohol Rev. 2006 Nov;25(6):611-24. doi: 10.1080/09595230600944529. Drug Alcohol Rev. 2006. PMID: 17132577 Review.
Cited by
-
Implementing referral to an electronic alcohol brief advice website in primary healthcare: results from the ODHIN implementation trial.BMJ Open. 2016 Jun 16;6(6):e010271. doi: 10.1136/bmjopen-2015-010271. BMJ Open. 2016. PMID: 27311902 Free PMC article. Clinical Trial.
-
Inbred mouse strain differences in alcohol and nicotine addiction-related phenotypes from adolescence to adulthood.Pharmacol Biochem Behav. 2022 Jul;218:173429. doi: 10.1016/j.pbb.2022.173429. Epub 2022 Jul 9. Pharmacol Biochem Behav. 2022. PMID: 35820468 Free PMC article. Review.
-
Stigma and discrimination related to mental health and substance use issues in primary health care in Toronto, Canada: a qualitative study.Int J Qual Stud Health Well-being. 2020 Dec;15(1):1744926. doi: 10.1080/17482631.2020.1744926. Int J Qual Stud Health Well-being. 2020. PMID: 32228393 Free PMC article.
-
Relationship between alcohol use and overactive bladder disease: a cross-sectional study of the NHANES 2005-2016.Front Public Health. 2025 Jan 3;12:1418117. doi: 10.3389/fpubh.2024.1418117. eCollection 2024. Front Public Health. 2025. PMID: 39830172 Free PMC article.
-
The effects of smoking, alcohol consumption, obesity, and physical inactivity on healthcare costs: a longitudinal cohort study.BMC Public Health. 2025 Mar 5;25(1):873. doi: 10.1186/s12889-025-22133-4. BMC Public Health. 2025. PMID: 40045251 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical